Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors
Authors:
- 1 June 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 24 (6) , 663-668
Abstract
Objective: To determine if interindividual genetic variation in single-nucleotide polymorphisms (SNPs) related to age at natural menopause is associated with risk of ovarian failure in breast cancer survivors. Methods: A prospective cohort of 169 premenopausal breast cancer survivors recruited at diagnosis with stages 0 to III disease were followed longitudinally for menstrual pattern via self-reported daily menstrual diaries. Participants were genotyped for 13 SNPs previously found to be associated with age at natural menopause: EXO1, TLK1, HELQ, UIMC1, PRIM1, POLG, TMEM224, BRSK1, and MCM8. A risk variable summed the total number of risk alleles in each participant. The association between individual genotypes, and also the risk variable, and time to ovarian failure (>12 months of amenorrhea) was tested using time-to-event methods. Results: Median age at enrollment was 40.5 years (range 20.6-46.1). The majority of participants were white (69%) and underwent chemotherapy (76%). Thirty-eight participants (22%) experienced ovarian failure. None of the candidate SNPs or the summary risk variable was significantly associated with time to ovarian failure. Sensitivity analysis restricted to whites or only to participants receiving chemotherapy yielded similar findings. Older age, chemotherapy exposure, and lower body mass index were related to shorter time to ovarian failure. Conclusions: Thirteen previously identified genetic variants associated with time to natural menopause were not related to timing of ovarian failure in breast cancer survivors.Keywords
This publication has 37 references indexed in Scilit:
- Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancerEuropean Journal of Cancer, 2013
- Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapyFertility and Sterility, 2013
- A genome-wide association study of early menopause and the combined impact of identified variantsHuman Molecular Genetics, 2013
- Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathwaysNature Genetics, 2012
- A large-scale candidate gene association study of age at menarche and age at natural menopauseHuman Genetics, 2010
- Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivorsFertility and Sterility, 2010
- Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapyCancer, 2010
- Loci at chromosomes 13, 19 and 20 influence age at natural menopauseNature Genetics, 2009
- A Pilot Study of Predictive Markers of Chemotherapy-Related Amenorrhea Among Premenopausal Women with Early Stage Breast CancerCancer Investigation, 2008
- HDC gene polymorphisms are associated with age at natural menopause in Caucasian womenBiochemical and Biophysical Research Communications, 2006